Myopia Management

ACUVUE® Abiliti® Overnight

Treat myopia while your child sleeps with Abiliti®

Overnight 

Acuvue Abiliti Overnight Package

Abiliti® Overnight Lenses - Treat Myopia While They Sleep

ACUVUE® Abiliti® Overnight Therapeutic Lenses are CE-marked orthokeratology (ortho-k) lenses that are approved for slowing the progression of myopia in children in Hong Kong, while typically providing glasses-free vision during the day.*†1,2

Girl asleep on her pillow

These lenses have been successfully used in thousands of patients for over 15 years in markets around the world.‡,2 An added benefit of Abiliti® Overnight can be that your child can be completely lens-free during the day, meaning they can participate in all activities, including water-sports, without worrying about glasses. †1 

How Do They Work?

When worn overnight, Abiliti® Overnight lenses temporarily reshape the surface of your child s eye while they sleep.3-6 This reshaping manages the progression of their myopia and lets them be glasses-free throughout the day. For most individuals, no other vision correction is needed. †1 

What Are the Benefits?

Slow myopia progression

Abiliti® Overnight lenses have been shown to reduce axial elongation by 0.28mm (on average) - equating to approximately 0.75D of myopia in just two years^,7-10

Clear glasses-free vision

Typically providing clear vision during the day without the need for eyeglasses or daytime contact lenses.†1

Better performance in school and sports

Kids wearing Ortho-K lenses report better performance in school and sports compared to wearing glasses. ^11

Boost your child's confidence

Children wearing ACUVUE® Abiliti® Overnight Therapeutic Lenses for Myopia Management report better rates of overall vision, far distance vision, symptoms, appearance, satisfaction, activities, academic performance, handling and peer perceptions than children wearing single-vision spectacles. ^11

Peace of mind

Because parents can help with insertion and removal at home, Abiliti® Overnight lenses are a good option for young children.

Woman on her laptop

Are They Safe And Comfortable To Wear?

In three studies accounting for over 200 patient-years of wear, no serious adverse events (or serious complications) were found with Abiliti Overnight lenses wear.7,9,12 The lenses were designed to keep eyes comfortable with features that help retain moisture and provide high oxygen flow.13 This means you can trust Abiliti Overnight lenses to work safely and comfortably when used as intended.14 Hear from Lamlam and her mum on their journey in managing myopia with Abiliti® Overnight.

Abiliti Overnight package

Which Abiliti lens is better for my child?

Abiliti® 1-Day lenses are another great option for slowing the progression of myopia. Instead of being worn at night like Abiliti® Overnight lenses, they are worn during the day to slow myopia progression and provide vision correction.15 These lenses are thrown away at the end of every day, making cleaning and care simple for kids on the go. An Abiliti® prescriber can help you decide which lens is right for your child. 

Abiliti App Platforms
Manage Myopia On-the-Go

Get the SeeAbiliti App to Manage Myopia On-the-Go

As part of our holistic approach to managing myopia, the SeeAbiliti app makes it easy to manage myopia on the go.
App Store

Download from App Store

SeeAbiliti on the App Store

Download now

Google Play

Download from Google play

SeeAbiliti on Google Play

Download now

Sight For Kids® Program

See Your Impact

Every child deserves the gift of clear sight. That s why Johnson & Johnson Vision is proud to support the Sight For Kids® program with our non-profit partner Lions Clubs International Foundation. You can be part of this global effort while enjoying the benefits of Abiliti® lenses.  Each annual purchase of an ACUVUE® Abiliti® product provides a free comprehensive eye exam to a child in need through Sight For Kids®. An eye exam can detect myopia and early warnings signs and manifestation of over 270 different medical conditions, and is important in maintaining overall eye health.16 To date, almost 48 million students globally have received eye exams, with over 500,000 children in need receiving eyeglasses.16

affectionate child with man

Resources

Understand how myopia can impact your child’s vision
and ways to help manage it.

References:

† Reducing refractive error up to 4.00D (sphere product) and up to 5.00D and up to 2.50D of astigmatism (toric product)


‡ Previously marketed under Menicon Z Night


^ Compared to single-vision spectacles.

References


1. Data on File 2023. Instruction for Use (CE Marketed Countries).


2. Data on File 2023. Menicon Initial CE approval 2006 


3. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2). 


4. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7. 


5. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.


6. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72. 


7. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13.2012;53(11):7077–85. 


8. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8). 


9. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7. 


10. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co-Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens. 2018 Jul;44(4):205-211


11. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia Control With Orthokeratology Contact Lenses in Spain: A Comparison of Vision-Related Quality-of-Life Measures Between Orthokeratology Contact Lenses and Single-Vision Spectacles. Eye & Contact Lens 2013; Volume 39, Number 2. 


12. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Orthokeratology vs. spectacles: adverse events and discontinuations. Optom Vis Sci. 2012 Aug;89(8):1133-9.


13. Data on File 2023. Menicon Internal Documentation


14. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses. 


15. American Academy of Optometry. Systemic Conditions with Ocular and Visual Manifestations. December 2014.


16. Lions Club International Foundation. Real impact: By the numbers. Available from: https://www.lionsclubs.org/en/resources-for-members/resource-center/sight-for-kids

HKM20240415_002

Clear Vision For You
Not actual patients or healthcare professionals. For illustrative purposes only.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Johnson & Johnson Vision, its subsidiaries or affiliates.

No use of any Johnson & Johnson Vision, trademark, trade name, or trade dress in this site may be made without the prior written authorization of Johnson & Johnson Vision, except to identify the product or services of the company. Third party trademarks are the property of their respective owners.


© Johnson & Johnson and its affiliates 2024